Panagiotis Tsourapas, an officer at Colgate-Palmolive, has filed a notice to sell 19,938 shares of the company’s common stock. This transaction is significant as it follows a previous sale of 10,000 shares in August 2026. The filing, dated November 4, 2026, indicates that the shares were sold through a cashless exercise of stock options.

The sale reflects Tsourapas's ongoing strategy to manage his equity compensation. Such transactions are common among executives who are often compensated with stock options as part of their remuneration package. This move may also indicate the executive's confidence in the company's future performance.

Background

Colgate-Palmolive Company is a leading global consumer goods company specializing in household, health care, and personal care products. The company is incorporated in Delaware and has a fiscal year ending on December 31. Colgate-Palmolive is well-known for its brands in the perfumes, cosmetics, and other toilet preparations sector, categorized under the SIC code 2844.

What the Filing Says

The filing states, "The nature of acquisition transaction is the exercise of employee stock options." It also notes that the shares were sold on the New York Stock Exchange (NYSE) with an aggregate market value of approximately $1,968,709.79.

Impact

This filing may affect shareholders and investors in Colgate-Palmolive, as it highlights the actions of its executives regarding stock ownership. Additionally, it may influence perceptions of the company's stock performance and executive compensation practices.

What's Next

The filing does not say what happens next.